SEBI Reg. Investment Advisor

Download App
Help Center Pricing
Money Works 4 Me Logo MoneyWorks4Me
Login Get Free Account
Sign Up

MoneyWorks4Me

Log In Sign Up Schedule Free 15‑min Call
Login Get Free Account
Sign Up

INVESTMENT INSIGHTS

Check Before You Invest : Astec Lifesciences Ltd

BSE: 533138 NSE: ASTEC ISIN: INE563J01010
  |   Sector:  Chemicals & Fertilizers   |   Industry:  Pesticides & Agrochemicals

Snapshot

Q.1 Which industry/sub-sector does Astec Lifesciences Ltd belong to?
Astec Lifesciences Ltd belongs to the Chemicals & Fertilizers sector, operating specifically within the Pesticides & Agrochemicals segment.
Q.2 Is Astec Lifesciences Ltd a good quality company?
Astec Lifesciences Ltd is a average quality company, based on a somewhat consistent 10 year financial track record.
Q.3 Is Astec Lifesciences Ltd undervalued or overvalued?
Astec Lifesciences Ltd appears Undervalued, as its key valuation ratios are below with their past averages.
Q.4 Is Astec Lifesciences Ltd a good buy now?
Astec Lifesciences Ltd is a good buy now, based on strong price trend analysis suggesting prices may rise. However, you need to check its quality and valuation before making a decision

Performance Analysis

Q.1 Revenue growth of Astec Lifesciences Ltd?
Astec Lifesciences Ltd revenue growth is -16.8% for FY-2025 , which is below its 5 year CAGR of -6.1% , indicating slower growth.
Q.2 Gross Profit margin of Astec Lifesciences Ltd?
Astec Lifesciences Ltd Gross profit margin which is the profit after deduction of direct costs, is -25% for FY-2025 , which is below its 5 year median of 10.9% , indicating decreasing margins.
Q.3 Operating Profit Margin of Astec Lifesciences Ltd?
Astec Lifesciences Ltd Operating Profit Margin which is the profit after deduction of all operating costs, is -17.36% for FY-2025 , which is below its 5 year median of 12.22% indicating decreasing margins.
Q.4 Net Profit Margin of Astec Lifesciences Ltd?
Astec Lifesciences Ltd Net Profit Margin is -35.33% for FY-2025 , is below with its 5 year median of 4.07%, indicating decreasing margins.
Current Level Historic Median
Gross Profit Margin -25 10.9
Operating Profit Margin -17.36 12.22
Net Profit Margin -35.33 4.07
Q.5 Return on Asset of Astec Lifesciences Ltd?
Astec Lifesciences Ltd Return on Asset is -14.47%, which is below its 5 year historical median of 2.69%, indicating deteriorated asset utilization efficiency.
Q.6 Return on Equity (ROE) of Astec Lifesciences Ltd?
Astec Lifesciences Ltd Return on equity is -44.64% for FY-2025 , which is below its historical median of 6.28%, indicating the business is making worse use of its shareholders capital.
Q.7 Return on capital employed (ROCE) of Astec Lifesciences Ltd?
Astec Lifesciences Ltd Return on capital employed is -12.62% for FY-2025 , which is below its estimated weighted average cost of capital(WACC) 14%, indicating value preservation.
Q.8 Cash conversion cycle of Astec Lifesciences Ltd?
Astec Lifesciences Ltd Cash conversion cycle is 238 days, above its historical median of 155 days, indicating deteriorated working capital management. However, you need to compare this with its peers in the industry.
Current Level Historic Median
Asset Turnover 0.42 0.66
ROE -44.64 6.28
ROCE -12.62 7.75
Cash Conversion Cycle 238 days 155 days
Q.9 Debt to Equity ratio of Astec Lifesciences Ltd?
Astec Lifesciences Ltd Debt-to-Equity ratio is 2.36 , which is above with the industry average of 0.27 , indicating higher debt levels in the industry.
Q.10 Debt to cash flow from operations of Astec Lifesciences Ltd?
Astec Lifesciences Ltd Debt to cash flow from operations is -66.03 , which is at a unhealthy level.

Ownership & governance

Q.1 Promoter shareholding and pledge status of Astec Lifesciences Ltd?
Promoters hold 71.97% of the Astec Lifesciences Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Peer comparison (industry-wise, mcap)

Q.1 Revenue growth of Astec Lifesciences Ltd vs industry peers?
Astec Lifesciences Ltd revenue CAGR is -6.11% , compared to the industry median CAGR of 8.45% , indicating slower growth and losing its market share.
Profit Metrics
Current Level Industry Median
Revenue 381.3 716.1
Gross Profit -95.3 68.5
Operating Profit -66 86
Net Profit -135 44
Operating Efficiency
Current Level Industry Median
Asset Turnover 0.42 1.19
ROE -44.64 13.63
ROCE -12.62 16.98
Cash Conversion Cycle (days) 237.97 93

Valuation & price assessment

Q.1 Stock return of Astec Lifesciences Ltd over the last decade?
Over the last 9 year(s), the stock has delivered a CAGR of 12.4% based on the current price.
Q.2 What return has the stock given over the last decade?
9Y 5Y 3Y 1Y
Share Price 12.4% -7.4% -20.1% -7.9%
Q.3 Valuation ratios of Astec Lifesciences Ltd vs historical?
The current P/E is lower that its historical median.
Q.4 How do the current valuation ratios measure up against the historic numbers and the current industry numbers?
Valuation Ratios Current Historic Median Industry Median
Price to Earnings - 34.70 24.15
Price to Book 3.96 8.59 2.51
Price to Sales 3.85 4.04 1.40
EV to EBITDA -392.18 19.67 12.63

Check more companies

1. Sumitomo Chemical
2. Bayer CropScience
3. Sharda Cropchem
4. Rallis India
5. Dhanuka Agritech
6. NACL Industries
7. Bhagiradha Chem
8. Bharat Rasayan
9. Insecticides India
10. GSP Crop Science
2026 ©The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me® is a registered trademark of The Alchemists Ark Pvt. Ltd.

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×